Intravitreal Injection of Dexamethasone Implant in Serous Macular Detachment Associated with Waldenström's Disease

PURPOSE: To evaluate the efficacy of one intravitreal injection of dexamethasone (Ozurdex(®); Allergan, Inc., Irvine, Calif., USA) in serous macular detachment (SMD) of one eye, associated with bilateral central retinal vein occlusion (CRVO) in a patient affected by Waldenström's macroglobuline...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Fenicia, Vito, Balestrieri, Marco, Perdicchi, Andrea, Maraone, Giorgia, Recupero, Santi Maria
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: S. Karger AG 2013
Aiheet:
Published online: July, 2013
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3764974/
https://ncbi.nlm.nih.gov/pubmed/24019788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000354066
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia